Patents by Inventor Anne Collin
Anne Collin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9850301Abstract: The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF8), in particular epitopes specific to GDF8 and other specific antagonists of GDF8 in particular anti-GDF8 antibodies or antigen binding protein or fragment thereof which may inhibit GDF8 activity and signal in vitro and/or in vivo. The disclosure also provides for an immunoassay used to detect and quantitate GDF8. The disclosure also provides methods for diagnosing, preventing, ameliorating, and treating GDF8-associated disorders, e.g., degenerative orders of muscle, bone, and insulin metabolism. Finally, the disclosure provides pharmaceuticals for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.Type: GrantFiled: August 7, 2016Date of Patent: December 26, 2017Assignee: PFIZER INC.Inventors: Edward Roland LaVallie, Lisa Anne Collins-Racie, Christopher John Corcoran, Lioudmila Gennadievna Tchistiakova, John Adam Nowak, Riyez Karim, Xiang-Yang Tan, Kimberly Ann Marquette, Geertruida Machteld Veldman
-
Publication number: 20170145084Abstract: The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF8), in particular epitopes specific to GDF8 and other specific antagonists of GDF8 in particular anti-GDF8 antibodies or antigen binding protein or fragment thereof which may inhibit GDF8 activity and signal in vitro and/or in vivo. The disclosure also provides for an immunoassay used to detect and quantitate GDF8. The disclosure also provides methods for diagnosing, preventing, ameliorating, and treating GDF8-associated disorders, e.g., degenerative orders of muscle, bone, and insulin metabolism. Finally, the disclosure provides pharmaceuticals for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.Type: ApplicationFiled: August 7, 2016Publication date: May 25, 2017Inventors: Edward Roland LaVallie, Lisa Anne Collins-Racie, Christopher John Corcoran, Lioudmila Gennadievna Tchistiakova, John Adam Nowak, Riyez Karim, Xiang-Yang Tan, Kimberly Ann Marquette, Geertruida Machteld Veldman
-
Publication number: 20170053073Abstract: Systems, methods, and apparatuses for treating a tissue site are described. In some embodiments, the method may include receiving input information related to a tissue site of a patient, processing the input information in a processor to generate options for a user to select a desired action, and executing the desired action to provide output information related to the tissue site. The method may further include communicating the output information to a user via a communications network.Type: ApplicationFiled: June 24, 2016Publication date: February 23, 2017Inventors: Diwi L. Allen, Gustavo GALAN, Hannah I. GROTHUES, Robert HILL, Barbara Anne COLLINS, Chester R. EDLUND, Kristine M. KIESWETTER, Somesh DASGUPTA, Joshua HAGGERTY
-
Patent number: 9409981Abstract: The disclosure provides novel molecules related to growth and differentiation factor 8 (GDF8), in particular epitopes specific to GDF8 and other specific antagonists of GDF8 in particular anti GDF8 antibodies or antigen binding protein or fragment thereof which may inhibit GDF8 activity and signal in vitro and/or in vivo. The disclosure also provides for an immunoassay used to detect and quantitate GDF8. The disclosure also provides methods for diagnosing, preventing, ameliorating, and treating GDF8 associated disorders, e.g., degenerative orders of muscle, bone, and insulin metabolism. Finally, the disclosure provides pharmaceuticals for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.Type: GrantFiled: March 8, 2013Date of Patent: August 9, 2016Assignee: Pfizer Inc.Inventors: Edward Roland LaVallie, Lisa Anne Collins-Racie, Christopher John Corcoran, Lioudmila Gennadievna Tchistiakova, John Adam Nowak, Riyez Karim, Xiang-Yang Tan, Kimberly Ann Marquette, Geertruida Machteld Veldman
-
Sleeves, manifolds, systems, and methods for applying reduced pressure to a subcutaneous tissue site
Patent number: 8795245Abstract: The illustrative embodiments described herein are directed to apparatuses, systems, and methods for applying reduced pressure to subcutaneous tissue site. In one illustrative embodiment, the apparatus includes a sleeve adapted for placement at a subcutaneous tissue site. The sleeve is further adapted to receive a manifold. The sleeve may also have an opening operable to transfer reduced pressure from the manifold to the subcutaneous tissue site. In one embodiment, the apparatus may also include a manifold that is insertable into the sleeve. The manifold may include at least one aperture, and may be operable to deliver reduced pressure to the subcutaneous tissue site via at least one aperture.Type: GrantFiled: December 22, 2009Date of Patent: August 5, 2014Assignee: KCI Licensing, Inc.Inventor: Barbara Anne Collins -
Publication number: 20140023638Abstract: The disclosure provides novel molecules related to growth and differentiation factor 8 (GDF8), in particular epitopes specific to GDF8 and other specific antagonists of GDF8 in particular anti GDF8 antibodies or antigen binding protein or fragment thereof which may inhibit GDF8 activity and signal in vitro and/or in vivo. The disclosure also provides for an immunoassay used to detect and quantitate GDF8. The disclosure also provides methods for diagnosing, preventing, ameliorating, and treating GDF8 associated disorders, e.g., degenerative orders of muscle, bone, and insulin metabolism. Finally, the disclosure provides pharmaceuticals for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.Type: ApplicationFiled: March 8, 2013Publication date: January 23, 2014Applicant: PFIZER INC.Inventors: Edward Roland LaVallie, Lisa Anne Collins-Racie, Christopher John Corcoran, Lioudmila Gennadievna Tchistiakova, John Adam Nowak, Riyez Karim, Xiang-Yang Tan, Kimberly Ann Marquette, Geertruida Machteld Veldman
-
Patent number: 8415459Abstract: The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF8), in particular epitopes specific to GDF8 and other specific antagonists of GDF8 in particular anti-GDF8 antibodies or antigen binding protein or fragment thereof which may inhibit GDF8 activity and signal in vitro and/or in vivo. The disclosure also provides for an immunoassay used to detect and quantitate GDF8. The disclosure also provides methods for diagnosing, preventing, ameliorating, and treating GDF8-associated disorders, e.g., degenerative orders of muscle, bone, and insulin metabolism. Finally, the disclosure provides pharmaceuticals for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.Type: GrantFiled: October 31, 2008Date of Patent: April 9, 2013Assignee: Pfizer Inc.Inventors: Edward Roland LaVallie, Lisa Anne Collins-Racie, Christopher John Corcoran, Lioudmila Gennadievna Tchistiakova, John Adam Nowak, Riyez Karim, Xiang-Yang Tan, Kimberly Ann Marquette, Geertruida Machteld Veldman
-
Publication number: 20120203144Abstract: Methods and systems of treating a hoof on an ungulate mammal involve delivering reduced pressure to an interior portion of a hoof to promote profusion. In one instance, a method includes forming one or more apertures in a hoof wall of the hoof proximate to laminae that is proximate to a phalanx (P3) of the hoof, disposing a distribution manifold proximate to the one or more apertures, covering the distribution manifold and a portion of the ungulate mammal's exterior tissue with a sealing member to form a sealed space in which the distribution manifold is disposed, and providing reduced pressure to the distribution manifold in the sealed space. Other methods and systems are also presented.Type: ApplicationFiled: January 20, 2012Publication date: August 9, 2012Inventor: Barbara Anne Collins
-
Patent number: 8153421Abstract: We describe a method for the isolation of prostate stem cells, typically prostate stem cells which express CD 133 antigen; stem cells and cancer stem cells isolated by the method and their use.Type: GrantFiled: March 18, 2005Date of Patent: April 10, 2012Assignee: Procure Therapeutics LimitedInventors: Norman James Maitland, Anne Collins
-
SLEEVES, MANIFOLDS, SYSTEMS, AND METHODS FOR APPLYING REDUCED PRESSURE TO A SUBCUTANEOUS TISSUE SITE
Publication number: 20100168692Abstract: The illustrative embodiments described herein are directed to apparatuses, systems, and methods for applying reduced pressure to subcutaneous tissue site. In one illustrative embodiment, the apparatus includes a sleeve adapted for placement at a subcutaneous tissue site. The sleeve is further adapted to receive a manifold. The sleeve may also have an opening operable to transfer reduced pressure from the manifold to the subcutaneous tissue site. In one embodiment, the apparatus may also include a manifold that is insertable into the sleeve. The manifold may include at least one aperture, and may be operable to deliver reduced pressure to the subcutaneous tissue site via at least one aperture.Type: ApplicationFiled: December 22, 2009Publication date: July 1, 2010Inventor: Barbara Anne Collins -
Publication number: 20090148436Abstract: The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF8), in particular epitopes specific to GDF8 and other specific antagonists of GDF8 in particular anti-GDF8 antibodies or antigen binding protein or fragment thereof which may inhibit GDF8 activity and signal in vitro and/or in vivo. The disclosure also provides for an immunoassay used to detect and quantitate GDF8. The disclosure also provides methods for diagnosing, preventing, ameliorating, and treating GDF8-associated disorders, e.g., degenerative orders of muscle, bone, and insulin metabolism. Finally, the disclosure provides pharmaceuticals for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.Type: ApplicationFiled: October 31, 2008Publication date: June 11, 2009Applicant: WyethInventors: Edward Roland LaVallie, Lisa Anne Collins-Racie, Christopher John Corcoran, Lioudmila Gennadievna Tchistiakova, John Adam Nowak, Riyez Karim, Xiang-Yang Tan, Kimberly Ann Marquette, Geertruida Machteld Veldman
-
Publication number: 20090012024Abstract: We disclose gene markers of stem cells, typically prostate stem cells, and in particular cancer stem cells, for example prostate cancer stem cells; therapeutic agents and diagnostic assays based on said stem cell genes; and including screening assays to identify therapeutic agents.Type: ApplicationFiled: July 19, 2006Publication date: January 8, 2009Applicant: Procure Therapeutics LimitedInventors: Anne Collins, Norman Maitland, Steven Bryce
-
Publication number: 20080233640Abstract: We describe a method for the isolation of prostate stem cells, typically prostate stem cells which express CD 133 antigen; stem cells and cancer stem cells isolated by the method and their use.Type: ApplicationFiled: March 18, 2005Publication date: September 25, 2008Applicant: Procure Therapeutics LimitedInventors: Norman James Maitland, Anne Collins
-
Publication number: 20030177598Abstract: A ticket scraper and method for the efficient production thereof using conventional plastic sheet printing and die-cutting techniques. Multiple scrapers of the same or varied designs are produced from a single sheet of plastic. The ticket scraper is effective for removing the obscuring surface of scratch-off tickets, but can be safely handled without risk to the user, the user's personal effects, or others. Production costs are minimized, while flexibility with respect to the appearance of the scraper produced is retained. Using conventional plastic sheet printing techniques, indicia comprised of a variety of shapes, designs and/or promotional logos/advertising are printed on a plastic sheet. Conventional die-cutting techniques are used to cut the scrapers from the printed plastic sheet.Type: ApplicationFiled: March 19, 2003Publication date: September 25, 2003Inventor: Anne Collins